DONA Glucosamine Injection — Arthritis Support

DONA is a pharmaceutical-grade glucosamine sulphate preparation used in the treatment of osteoarthritis, where cartilage degradation leads to progressive joint pain and stiffness. At IVC Olomouc, DONA is delivered by intramuscular injection at 200 Kč per dose — the injectable route achieves higher and more consistent plasma concentrations than oral glucosamine tablets, which have variable bioavailability. Clinical research supports glucosamine sulphate for reducing pain and improving joint function in knee and hip osteoarthritis, and the Czech medical community has used DONA injections as part of arthritis management for many years.

Glucosamine sulphate is an aminosaccharide that serves as a substrate for the biosynthesis of glycosaminoglycans and proteoglycans — the structural components of articular cartilage, synovial fluid, and connective tissue. In osteoarthritis, the progressive breakdown of cartilage matrix outpaces its repair, leading to pain, stiffness, and loss of function. Glucosamine may slow this process by providing building blocks for cartilage synthesis, reducing the activity of enzymes that degrade cartilage matrix, and exerting mild anti-inflammatory effects. The DONA brand (manufactured by Rottapharm) is a crystalline glucosamine sulphate that has been studied in multiple randomised controlled trials, including the GUIDE study and the GAIT trial, with evidence supporting modest but consistent benefits in knee osteoarthritis pain and function over three to six months of use. The injectable form at IVC Olomouc bypasses the first-pass metabolism and variable gut absorption that affect oral glucosamine, delivering the compound directly to systemic circulation from intramuscular tissue. The injection is brief — approximately ten to fifteen minutes including preparation and observation — and is administered into a large muscle. A course of injections is typically recommended rather than a single dose; the practitioner will advise on the appropriate number and frequency based on severity and response. At 200 Kč per injection, DONA at IVC Olomouc is a cost-effective option for patients with osteoarthritic joint pain who want to try the parenteral route after limited response to oral glucosamine, or who prefer the certainty of injectable bioavailability from the start.